Design and baseline characteristics of the LANDMARK study.

Hiroaki OgataMasafumi FukagawaHideki HirakataHideaki KanedaTatsuo KagimuraTadao Akizawanull null

Published in: Clinical and experimental nephrology (2016)

The LANDMARK study will determine whether LC, a non-Ca-based P binder, reduces cardiovascular mortality and morbidity in chronic hemodialysis patients.

Keyphrases

mass spectrometry
coronary artery disease
risk factors
cardiovascular events
high resolution
simultaneous determination
liquid chromatography